Characterization of hydroxyl radical modified GAD₆₅: A potential autoantigen in type 1 diabetes

References

• Yoon JW, Jun HS. Insulin-dependent diabetes mellitus. Encyclopedia of Immunology2nd ed., IM Roitt, PJ Delves. Academic Press, London 1998; 1390–1398
   Google Scholar
• Banchuin N, Boonyasrisawat W, Vannasaeng S, Dharakul T, Yenchitsomanus P, Deerochanawong C, Polybutr S, Sriussadaporn S, Pasurakul T. Cell-mediated immune responces to GAD and β-casein in type 1 diabetes mellitus in Thailand. Diab Res Clin Pract 2002; 55: 237–245
   Google Scholar
• Atkinson MA, Eisenbarth GS. Type 1 diabetes: New perspectives on disease pathogenesis and treatment. Lancet 2001; 358: 221–229
   PubMed Web of Science ®Google Scholar
• Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994; 331: 1428–1436
   PubMed Web of Science ®Google Scholar
• Banchuin N, Vannasaeng S, Polybutr S, Sriussadaporn S. Comparison of anti-human insulin antibodies detection by commercial enzyme-linked immunosorbent assay kit, displacement enzyme-linked immunosorbent assay and radioimmunoassay, in Thai diabetic patients. Diab Res Clin Pract 1993; 22: 71–82
   Google Scholar
• Bingley PJ, Bonifacio E, Shattock M, Gillmor HA, Sawtell P, Dunger DB, Scott RDM, Bottazzo GF, Gale EAM. Can islet cell autoantibodies predict IDDM in the general population?. Diabetes Care 1993; 16: 45–50
   PubMed Web of Science ®Google Scholar
• Hampe CS, Hammerle LP, Bekris L, Örtqvist E, Kockum I, Rolandsson O, Landin-Olsson M, Törn C, Persson B, Lernmark A. Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different gad antibody-positive phenotypes. J Clin Endocrinol Metab 2000; 85(12)4671–4679
   PubMedGoogle Scholar
• Erlander MG, Tillakaratne NJK, Feldblum S, Patel N, Tobin AJ. Two genes encode distinct glutamate decarboxylase. Neuron 1991; 7: 91–100
   PubMed Web of Science ®Google Scholar
• Bu DF, Erlander MG, Hitz BC, Tillakaratne NJ, Kaufman DL, Wagner-McPherson CB, Evans GA, Tobin AJ. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci USA 1992; 89: 2115–2119
   PubMed Web of Science ®Google Scholar
• Erlander MG, Tobin AJ. The structural and functional heregeneity of glutamic acid decarboxylase: A review. Neurochem Res 1991; 16: 215–226
   PubMed Web of Science ®Google Scholar
• Bonifacio E, Atkinson M, Eisenbarth G, Serreze D, Kay TW, Lee-Chan E, Singh B. International workshop on lessons from animal models for human type 1 diabetes: Identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes 2001; 50: 2451–2458
   PubMed Web of Science ®Google Scholar
• Raju R, Foote J, Banga JP, Hall TR, Padoa CJ, Dalakas MC, Ortqvist E, Hampe CS. Analysis of GAD65 autoantibodies in stiff-person syndrome patients. J Immunol 2005; 175: 7755–7762
   PubMedGoogle Scholar
• Seissler J, Bieg S, Yassin N, Mauch L, Northemann W, Boehm BO, Scherbaum WA. Association between antibodies to the MR 67,000 isoform of glutamate decarboxylase (GAD) and type 1 (insulin-dependent) diabetes mellitus with coexisting autoimmune polyendocrine syndrome type 2. Autoimmunity 1994; 19: 231–238
   PubMed Web of Science ®Google Scholar
• Hallengren B, Falorni A, Landin-Olsson M, Lernmark A, Papadopoulos KI, Sundkvist G. Islet cell and glutamic acid decarboxylase antibodies in hyperthyroid patients – at diagnosis and following treatment. J Intern Med 1996; 239: 63–68
   Google Scholar
• Ujihara N, Daw K, Gianani R, Boel E, Yu L, Powers AC. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type 1 diabetes. Diabetes 1994; 43: 968–975
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Tanaka S, Okubo M, Nakanishi K, Murase T, Lernmark A. Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes. J Clin Endocrinol Metabol 2003; 88: 4768–4775
   Google Scholar
• Hall TR, Bogdani M, LeBoeuf RC, Kirk EA, Maziarz M, Banga JP, Oak S, Pennington CA, Hampe CS. Modulation of diabetes in NOD mice by GAD65-specific monoclonal antibodies is epitope specific and accompanied by anti-idiotypic antibodies. Immunology 2008; 123: 547–554
   PubMed Web of Science ®Google Scholar
• Villalba A, Iacono RF, Valdez SN, Poskus E. Detection and immunochemical characterization of glutamic acid decarboxylase autoantibodies in patients with autoimmune diabetes mellitus. Autoimmunity 2008; 41: 143–153
   PubMed Web of Science ®Google Scholar
• Nazirogilu M, Butterworth P. Protective effect of moderate exercise with dietary vitamin C and E on blood antioxidative defense mechanism in rats with streptozotocin induced diabetes. Canad J Appl Physiol 2005; 30: 172–185
   Google Scholar
• Nerup J, Mandrup-Poulsen T, Helqvist S, Andersen HU, Pociot F, Reimers JI, Cuartero BG, Karlsen AE, Bjerre U, Lorenzen T. On the pathogenesis of IDDM. Diabetologia 1994; 37: 82–89
   PubMedGoogle Scholar
• Rasheed Z, Khan MWA, Ali R. Hydroxyl radical modification of human serum albumin generated cross reactive antibodies. Autoimmunity 2006; 39: 479–488
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–254
   PubMed Web of Science ®Google Scholar
• Chen YH, Yang JT, Martinez H. Determination of the secondary structure of proteins by circular dichroism and optical rotatory dispersion. Biochemistry 1972; 11: 4120–4131
   PubMed Web of Science ®Google Scholar
• Khan MWA, Rasheed Z, Ali R. Biochemical, biophysical and thermodynamic analysis of in vitro glycated human serum albumin. Biochemistry (Moscow) 2007; 72: 146–152
   Google Scholar
• Rasheed Z, Ahmad R, Rasheed N, Ali R. Reactive oxygen species damaged human serum albumin in patients with hepatocellular carcinoma. J Exp Clin Cancer Res 2007; 26: 395–404
   PubMed Web of Science ®Google Scholar
• Habib S, Moinuddin, Ali R. Peroxynitrite-modified DNA: A better antigen for systemic lupus erythematosus anti-DNA autoantibodies. Biotechnol Appl Biochem 2006; 43: 65–70
   PubMedGoogle Scholar
• Khan WA, Habib S, Khan WA, Alam K, Moinuddin. Enhanced binding of circulating SLE autoantibodies to cathecholestrogen-copper-modified DNA. Mol Cell Biochem 2008; 315: 143–150
   PubMedGoogle Scholar
• Laemilli UK. Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
   Google Scholar
• Oakley BR, Kirch DR, Morris ND. A simplified ultra sensitive silver stain for detecting proteins in polyacrylamide gel. Anal Biochem 1980; 105: 361–362
   PubMed Web of Science ®Google Scholar
• Goding JW. Use of staphylococcal protein-A as immunological reagent. J Immunol Meth 1978; 20: 241–254
   PubMed Web of Science ®Google Scholar
• Levine LR, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER. Determination of carbonyl content in oxidatively modified proteins. Meth Enzymol 1990; 186: 464–478
   PubMed Web of Science ®Google Scholar
• Langmuir I. The adsorption of gases on plane surface glass, mica and platinum. J Am Chem Soc 1918; 40: 1361–1403
   Web of Science ®Google Scholar
• Chetyrkin SV, Mathis ME, Ham AJ, Hachey DL, Hudson BG, Voziyan PA. Propagation of protein glycation damage involves modification of tryptophan residues via reactive oxygen species: Inhibition by pyridoxamine. Free Radic Biol Med 2008; 44: 1276–1285
   PubMed Web of Science ®Google Scholar
• Karlsen AE, Hagopian WA, Grubin CE, Dube S, Disteche CM, Adler DA, Bärmeier H, Mathewes S, Grant FJ, Foster D, et al. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci USA 1991; 88: 8337–8341
   PubMed Web of Science ®Google Scholar
• Manavalan P, Johnson WC, Jr. Sensitivity of circular dichroism to protein tertiary structure class. Nature 1983; 305: 831–832
   Web of Science ®Google Scholar
• Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257–267
   PubMed Web of Science ®Google Scholar
• Kim RH, Kwon OJ, Park JW. Ceruloplasmin enhances DNA damage induced by cysteine/iron in vitro. Biochimie 2001; 83: 487–495
   Google Scholar
• Kawasaki E, Abiru N, Eguchi K. Prevention of type 1 diabetes: From the view point of β-cell damage. Diab Res Clin Pract 2004; 66: 27–32
   PubMed Web of Science ®Google Scholar
• Dalle-Dome I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clinica Chimica Acta 2003; 29: 23–38
   Google Scholar